Professor Verena V. Hafner is a leading researcher at Humboldt University of Berlin's Institute of Computer Science, specializing in the intersection of artificial intelligence, cognitive science, and clinical neuroscience. Her work focuses on embodied computational models of self-awareness and predictive processing. Current major projects include: Principal investigator for DFG Priority Program 'An Embodied AI Approach to Measures of the Self' Co-responsible for 'Functional aspects of the minimal self – the case of schizophrenia' Key contributor to Cluster of Excellence 'Science of Intelligence (SCIoI)' Co-responsible for 'Information Integration in Predictive Processes' Her research uniquely bridges computational modeling with clinical applications in schizophrenia research. Previously, she contributed to Research Training Group 1324 on disaster management systems. Professor Hafner's work demonstrates how AI can provide mechanistic explanations for cognitive phenomena through embodied approaches, with significant implications for both artificial intelligence development and understanding psychiatric conditions.
Elena Ratner, MD, MBA, is a Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine and Co-Chief of the Section of Gynecologic Oncology. She is Board Certified in Gynecologic Oncology with special expertise in cytoreductive surgery for advanced ovarian cancer, minimally invasive procedures including robotics, and fertility-sparing surgery for young cancer patients. Dr. Ratner's research focuses on developing targeted drugs for ovarian cancer to provide personalized care and reversing chemotherapy resistance in ovarian and uterine cancers. Her laboratory work investigates novel antibody-drug conjugates targeting TROP2 and HER2, RAF/MEK inhibition combined with FAK inhibition for low-grade serous ovarian cancer, and immunotherapy approaches for endometrial cancers with microsatellite instability. Her recent publications (2024-2025) demonstrate a strong focus on translational research with numerous preclinical studies moving toward clinical applications. She has received multiple clinical and teaching awards, including the 2015 Yale Cancer Center Award for Clinical Excellence, and has been named among Yale Medicine's 'Top Doctors' in 2023 and 2024. Co-director of Discovery To Cure Director of Discovery to Cure Early Ovarian Cancer Detection program Founder and director of the Sexuality, Intimacy and Menopause cancer survivorship program (SIMS) Sub-investigator on multiple active clinical trials including studies on novel antibody-drug conjugates and surgical prevention strategies Dr. Ratner is particularly known for her advocacy for cancer survivors and emphasis on quality of life issues. She facilitates one-on-one mentoring for patients and stresses the importance of social networks during cancer treatment, believing that 'it is so important for women who need to know that they are not alone in this fight.'
Ali Mesbah is a Professor in the Department of Electrical and Computer Engineering at the University of British Columbia (UBC), where he leads the SALT lab. His research focuses on software engineering with emphasis on AI-driven software analysis, software testing, and software evolution. Previously, he was a Visiting Research Scientist at Google during 2017-2018. Dr. Mesbah received his BSc/MSc (2003) and PhD (2009) degree cum laude in Computer Science from the Delft University of Technology (TUDelft). After completing a postdoctoral fellowship with the Software Engineering Research Group at TUDelft and a Visiting Researcher position at Fujitsu Laboratories of America, he joined UBC in 2011. His research interests span software engineering with particular focus on AI-driven software analysis, software testing, software evolution, program comprehension, fault localization and repair. His work has significant applications in web application testing, JavaScript analysis, and automated program repair. He has pioneered techniques for testing modern web applications, analyzing JavaScript code, and leveraging AI for software maintenance tasks. His recent publications demonstrate a clear evolution toward integrating large language models with traditional program analysis techniques, focusing on test generation, bug repair, and understanding multi-hunk patches. His work bridges theoretical software engineering concepts with practical applications, particularly in web technologies and AI-assisted development. Amazon Research Award (2023) Killam Accelerator Research Fellowship (KARF) (2020) Killam Faculty Research Prize (2019) NSERC Discovery Accelerator (DAS) award (2016) ACM Distinguished Paper Awards at ICSE (2009, 2014) IEEE Distinguished Paper Award at ICST (2018) Best Paper Award at ESEM (2015) Best Paper Award at ICWE (2013) Dr. Mesbah has advised numerous PhD and MASc students, many of whom have gone on to positions at leading technology companies including Google, Amazon, Apple, Microsoft, and SAP. His research has been supported by various grants including the Amazon Research Award and NSERC funding. He leads the SALT lab at UBC, which focuses on software analysis, testing, and learning, with current research directions including AI-driven software engineering, web application testing, and program repair. The lab maintains active collaborations with industry partners and academic institutions worldwide.
Rahman Omidinia Anarkoli is a Postdoctoral Researcher at RWTH Aachen University, working within the De Laporte Research Group. His contact information shows affiliation with Room A-2.14 and phone number +49 241 80-23341, indicating his position within the university's research infrastructure. He actively contributes to multiple research projects including BioArchitecture, Anisogel, and µTISSUEfab. Dr. Omidinia specializes in developing advanced fabrication methodologies for tissue engineering applications. His research focuses on creating biomimetic 3D tissue constructs using 3D bioprinting, fiber spinning, and microfluidics techniques. He designs minimally invasive scaffolds that respond to external stimuli like magnetic fields to create anisotropic microenvironments mimicking native tissues such as muscle, tendon, and spinal cord. His work bridges the gap between in vitro tissue models and in vivo regenerative biomaterials, with particular emphasis on neural tissue engineering and organ-specific fibrosis models. Analysis of his publication record from 2017-2025 reveals a strong focus on neural regeneration, with multiple studies on axon guidance in 3D hydrogels and nerve extension using specialized biomaterials. His more recent work has expanded into kidney fibrosis modeling and advanced microgel production techniques. The research demonstrates consistent evolution from foundational work on nerve guidance (2017-2020) toward more complex organ models and scalable production methods (2021-2025). Dr. Omidinia collaborates extensively with Professor Laura De Laporte's research group, appearing as co-author on all his publications. His research is supported through various projects including the Leibniz SAW Female Professors Program BioMat and the Anisogel project focused on spinal cord repair. He also contributes to projects addressing tissue adhesion prevention (AparTextile) and cultured meat development (HydroSpin). The researcher is involved with multiple advanced laboratory initiatives including µTISSUEfab for high-throughput screening of human tissue models, AnisoPlate for preclinical tissue testing, and BioArchitecture for complex tissue-mimicking structures. These projects demonstrate his integration into a comprehensive tissue engineering research ecosystem at RWTH Aachen University.
